Cargando…

Identification of immune-related target and prognostic biomarkers in PBMC of hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide, and is characterized by insidious onset, rapid progression, and poor prognosis. Immunotherapy is a first-line treatment for advanced HCC. The identification of immune-related prognostic markers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Rui, Zhang, Wei, Han, Zhiyi, Ma, Mengqing, Huang, Qi, Lv, Minling, Ma, Wenfeng, Sun, Xinfeng, Feng, Wenxing, Li, Jing, Zhong, Xin, Sun, Jialing, Yao, Wei, Zhou, Xiaozhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337054/ https://www.ncbi.nlm.nih.gov/pubmed/37438735 http://dx.doi.org/10.1186/s12876-023-02843-y

Ejemplares similares

RNA-seq profiling reveals PBMC RNA as a potential biomarker for hepatocellular carcinoma
por: Han, Zhiyi, et al.
Publicado: (2021)

High-throughput screening identification of a small-molecule compound that induces ferroptosis and attenuates the invasion and migration of hepatocellular carcinoma cells by targeting the STAT3/GPX4 axis
por: Huang, Qi, et al.
Publicado: (2023)

Role of liensinine in sensitivity of activated macrophages to ferroptosis and in acute liver injury
por: Li, Jing, et al.
Publicado: (2023)

Qizhu Anti-Cancer Recipe promotes anoikis of hepatocellular carcinoma cells by activating the c-Jun N-terminal kinase pathway
por: Han, Zhiyi, et al.
Publicado: (2023)

FAT4 expression in peripheral blood mononuclear cells is associated with prognosis and immune cell infiltration in hepatocellular carcinoma
por: Li, Jing, et al.
Publicado: (2023)

Germacrone induces caspase-3/GSDME activation and enhances ROS production, causing HepG2 pyroptosis
por: Sun, Xinfeng, et al.
Publicado: (2022)

CircRNA expression profiling of PBMCs from patients with hepatocellular carcinoma by RNA-sequencing
por: Han, Zhiyi, et al.
Publicado: (2021)

Full spectrum flow cytometry-powered comprehensive analysis of PBMC as biomarkers for immunotherapy in NSCLC with EGFR-TKI resistance
por: Zhou, Juan, et al.
Publicado: (2023)

Identification and Validation of Stage-Associated PBMC Biomarkers in Breast Cancer Using MS-Based Proteomics
por: Moradpoor, Raheleh, et al.
Publicado: (2020)

Identification of an Epigenetic Signature for Coronary Heart Disease in Postmenopausal Women's PBMC DNA
por: Zhong, Xiao, et al.
Publicado: (2022)

Identification and validation of EPHX2 as a prognostic biomarker in hepatocellular carcinoma
por: Zhan, Ke, et al.
Publicado: (2021)

Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma
por: Yang, Bo, et al.
Publicado: (2020)

Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma
por: Deng, Xiaoyu, et al.
Publicado: (2021)

Identification of Arp2/3 Complex Subunits as Prognostic Biomarkers for Hepatocellular Carcinoma
por: Huang, Shenglan, et al.
Publicado: (2021)

Identification of PBMC-based molecular signature associational with COVID-19 disease severity
por: Shaath, Hibah, et al.
Publicado: (2021)

MARCKS is a New Prognostic Biomarker in Hepatocellular Carcinoma
por: Lu, Haoran, et al.
Publicado: (2023)

Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2022)

The effects of storage temperature on PBMC gene expression
por: Yang, Jun, et al.
Publicado: (2016)

Anti-Tumor Activity of Expanded PBMC-Derived NK Cells by Feeder-Free Protocol in Ovarian Cancer
por: Chen, Minhua, et al.
Publicado: (2021)

Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma
por: Liao, Xiwen, et al.
Publicado: (2018)

Identification of Tumorigenic and Prognostic Biomarkers in Colorectal Cancer Based on microRNA Expression Profiles
por: Shi, Yuntao, et al.
Publicado: (2020)

Eg5 as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma
por: Shao, Yu-Yun, et al.
Publicado: (2021)

Systems biology analysis of immune signaling in peripheral blood mononuclear cells (PBMC) of melanoma patients receiving ipilimumab; basis for response biomarker identification
por: Hotson, Drew, et al.
Publicado: (2014)

Identification of CELSR2 as a novel prognostic biomarker for hepatocellular carcinoma
por: Xu, Mingxing, et al.
Publicado: (2020)

Identification of Key Genes in Purine Metabolism as Prognostic Biomarker for Hepatocellular Carcinoma
por: Su, Wen-Jing, et al.
Publicado: (2021)

Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma
por: Qi, Zhenhua, et al.
Publicado: (2020)

Identification of Therapeutic Targets and Prognostic Biomarkers among Genes from the Mediator Complex Family in the Hepatocellular Carcinoma Tumour-Immune Microenvironment
por: Tan, Wei, et al.
Publicado: (2022)

Identification of Prognostic Biomarkers Associated with Cancer Stem Cell Features in Prostate Adenocarcinoma
por: Zhang, Dehua, et al.
Publicado: (2020)

Downregulated TICAM1 is a prognostic biomarker and associated with immune tolerance of Wilms tumor patients
por: Lu, Zhiyi, et al.
Publicado: (2022)

Identification and Validation of a Prognostic Model Based on Three Autophagy-Related Genes in Hepatocellular Carcinoma
por: Qin, Fanbo, et al.
Publicado: (2021)

PBMC telomerase activity in depression and the response to electroconvulsive therapy
por: Ryan, Karen M., et al.
Publicado: (2021)

Optimized workflow for human PBMC multiomic immunosurveillance studies
por: Genge, Palak C., et al.
Publicado: (2021)

Impact of Cryopreservation on Viability, Phenotype, and Functionality of Porcine PBMC
por: Li, Yanli, et al.
Publicado: (2021)

Nudix hydrolase 1 is a prognostic biomarker in hepatocellular carcinoma
por: Ou, Qifeng, et al.
Publicado: (2020)

Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis
por: Zhen, Zili, et al.
Publicado: (2021)

Expression And Biological Interaction Network Of RHOC For Hepatic Carcinoma With Metastasis In PBMC Samples
por: Shen, Yanting, et al.
Publicado: (2019)

Identification of Potential Prognostic Biomarkers Associated With Macrophage M2 Infiltration in Gastric Cancer
por: Liu, Baohong, et al.
Publicado: (2022)

GDI2 is a novel diagnostic and prognostic biomarker in hepatocellular carcinoma
por: Zhang, Wen, et al.
Publicado: (2021)

Identification of therapeutic targets and prognostic biomarkers in cholangiocarcinoma via WGCNA
por: Xu, Lei, et al.
Publicado: (2022)

Systems biology analysis of immune signaling in peripheral blood mononuclear cells (PBMC) of melanoma patients receiving ipilimumab; basis for clinical response biomarker identification
por: Hotson, Drew, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rpd13i7n2su5tnbhuk22l11i51